With a brokerage advising to sell above 75 cents, this has become a trading stock in the short term. Only when BNC105 results are released by end of June or early July, stock will either take off to the next level or fall back below 50 cents. If the results are good, there will be an accelerated increase in price because Bionomics will have more mojo in negotiations for BNC210 licensing. Of course, the other side would be a mild disaster. Hold on to your shares and enojy the ride!
Add to My Watchlist
What is My Watchlist?